Active ingredients

DAPAVELDACTIN 5 mg® :

• Film Coated Tablets

• Each Film Coated tablet contains dapagliflozin propanediol monohydrate 6.15 mg equivalent to 5 mg dapagliflozin.

Leaflet, registration license, and pack

Price: 50 L.E/ 1 Strip (7 tablets)

DAPAVELDACTIN 10 mg® :

• Film Coated Tablets

• Each Film Coated tablet contains dapagliflozin propanediol monohydrate 12.30 mg equivalent to 10 mg dapagliflozin.

Leaflet, registration license, and pack

Price: 70 L.E / 1 Strip (7 tablets)

Indications

Type 2 Diabetes Mellitus

DAPAVELDACTIN® (dapagliflozin) is indicated:

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

• To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.

Heart Failure

DAPAVELDACTIN® is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction.

• To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.